Pandemic-Related Stressors Linked to Cannabis and Nicotine Use in a Longitudinal Study of Asian, Latinx, and White Young Adults

一项针对亚裔、拉丁裔和白人青年人的纵向研究表明,疫情相关压力与大麻和尼古丁的使用有关

阅读:1

Abstract

OBJECTIVE: Systemic inequities are associated with stressor experiences of racial and ethnic minoritized individuals and disparities in health and substance use. Recently, young adults (YAs) have experienced pandemic-related stressors, but the differences in exposure and their long-term implications for substance use are not well understood. We examined associations of pandemic-related stressors with alcohol, cannabis, and nicotine use among non-Latinx (NL) Asian, Latinx, and NL White YAs in the context where the use of these substances is legal for those 21 and older. METHOD: We used data from a statewide longitudinal (2019-2022) sample of YAs in Washington State (N = 3,646; 13.8% NL Asian, 16.6% Latinx, and 69.6% NL White; 74.9%, 75.1%, and 74.2% female, respectively). Stressors in 2020 were regressed on race, ethnicity, and 2019 background covariates. Substance use outcomes (modeled as latent variables of use in 2020-2022) were regressed on race and ethnicity, 2020 stressors, and background covariates. RESULTS: Latinx YAs experienced more pandemic-related stressors than NL White YAs. Across 2020-2022 and adjusting for use in 2019, Latinx YAs reported more cannabis use days, and NL Asian YAs reported fewer cannabis and alcohol use days, than NL White YAs. Stressors were positively and significantly associated with cannabis, cigarette, and e-cigarette use in 2020-2022 but were not strongly associated with alcohol use. Associations between substance use and stressors were similar across groups. CONCLUSIONS: Pandemic-related stressors may have long-term implications for YAs' substance use, and these stressors are an area of emphasis for preventive interventions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。